CCR7 and cancer: Following a 4-hour incubation with cancer cells, we stained the PBMCs to identify CD45+ CD3+ CD8+ CCR7+ T-cells (CD8+ TCM) and measured their expression of PD-1 and CD107a (Scheme, Fig. 6B).